DCF — FRANCISCAN HEALTH RENSSELAER
Enterprise Value: $-93.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-93.4M
Enterprise Value
$-28.7M
PV of Cash Flows
$-64.7M
PV of Terminal Value
$-104.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $32.4M | $-6.3M | -19.0% | $-7.7M | $-7.0M |
| Year 2 | $33.4M | $-6.1M | -18.0% | $-7.6M | $-6.2M |
| Year 3 | $34.4M | $-6.0M | -17.0% | $-7.4M | $-5.6M |
| Year 4 | $35.4M | $-6.0M | -17.0% | $-7.5M | $-5.1M |
| Year 5 | $36.5M | $-6.1M | -17.0% | $-7.6M | $-4.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-93.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$31.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.19923272960568775
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5